אלפו-קל XL ישראל - עברית - Ministry of Health

אלפו-קל xl

padagis israel agencies ltd, israel - alfuzosin hydrochloride - טבליות בשחרור ממושך - alfuzosin hydrochloride 10 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason.

מילנאבניר  25 מג ישראל - עברית - Ministry of Health

מילנאבניר 25 מג

bioavenir ltd, israel - milnacipran as hydrochloride - קפסולות - milnacipran as hydrochloride 25 mg - milnacipran

מילנאבניר  50 מג ישראל - עברית - Ministry of Health

מילנאבניר 50 מג

bioavenir ltd, israel - milnacipran as hydrochloride - קפסולות - milnacipran as hydrochloride 50 mg - milnacipran

ריפאליד 0.5 מג ישראל - עברית - Ministry of Health

ריפאליד 0.5 מג

padagis israel agencies ltd, israel - repaglinide - טבליה - repaglinide 0.5 mg - repaglinide

ריפאליד 1 מג ישראל - עברית - Ministry of Health

ריפאליד 1 מג

padagis israel agencies ltd, israel - repaglinide - טבליה - repaglinide 1 mg - repaglinide

ריפאליד 2 מג ישראל - עברית - Ministry of Health

ריפאליד 2 מג

padagis israel agencies ltd, israel - repaglinide - טבליה - repaglinide 2 mg - repaglinide

רבלימיד 5 מג ישראל - עברית - Ministry of Health

רבלימיד 5 מג

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

רבלימיד 5 מג ישראל - עברית - Ministry of Health

רבלימיד 5 מג

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

רבלימיד 10 מג ישראל - עברית - Ministry of Health

רבלימיד 10 מג

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 10 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

רבלימיד 10 מג ישראל - עברית - Ministry of Health

רבלימיד 10 מג

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 10 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.